The Many Faces of Apomorphine Lessons from the Past and Challenges for the Future - Comportement et noyaux gris centraux EA4712 Accéder directement au contenu
Article Dans Une Revue Drugs in R&D Année : 2018

The Many Faces of Apomorphine Lessons from the Past and Challenges for the Future

Résumé

Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson's disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This paper traces the history of apomorphine, from its earliest empirical use, to its synthesis, pharmacological development, and numerous indications in human and veterinary medicine, in light of its most recent uses and newest challenges. From shamanic rituals in ancient Egypt and Mesoamerica, to the treatment of erectile dysfunction, from being discarded as a pharmacological tool to becoming an essential antiparkinsonian drug, the path of apomorphine in the therapeutic armamentarium has been tortuous and punctuated by setbacks and groundbreaking discoveries. Throughout history, three main clinical indications stood out: emetic (gastric emptying, respiratory disorders, aversive conditioning), sedative (mental disorders, clinical anesthesia, alcoholism), and antiparkinsonian (fluctuations). New indications may arise in the future, both in PD (palliative care, nonmotor symptoms, withdrawal of oral dopaminergic medication), and outside PD, with promising work in neuroprotection or addiction.

Domaines

Pharmacologie
Fichier principal
Vignette du fichier
10.1007%2Fs40268-018-0230-3.pdf (1.02 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01808251 , version 1 (10-10-2018)

Identifiants

Citer

Manon Auffret, Sophie Drapier, Marc Vérin. The Many Faces of Apomorphine Lessons from the Past and Challenges for the Future. Drugs in R&D, 2018, 18 (2), pp.91-107. ⟨10.1007/s40268-018-0230-3⟩. ⟨hal-01808251⟩
38 Consultations
201 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More